Related Experiment Video
Updated: Jun 7, 2026

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0
Published on: June 5, 2017
Modeling and simulation of inverse agonism dynamics
1Centre for Mathematical Medicine and Biology, School of Mathematical Sciences, University of Nottingham, United Kingdom.
Inverse agonists modulate G-protein coupled receptor (GPCR) signaling by inhibiting constitutive activity. Mathematical modeling reveals complex dynamic behaviors, aiding drug design for GPCR targets.
Area of Science:
- Pharmacology
- Computational Biology
- Biophysics
Background:
- G-protein coupled receptors (GPCRs) exhibit constitutive activity, a phenomenon recognized with the advent of inverse agonists.
- Understanding the signaling mechanisms of inverse agonists on constitutively active GPCRs is crucial.
- Quantitative analysis and predictive modeling are essential for drug design targeting GPCRs.
Purpose of the Study:
- To review the concept of inverse agonism in the context of GPCR signaling.
- To describe the application of mathematical and computational techniques to model inverse agonists.
- To elucidate the signaling mechanisms and predict physiological responses to inverse agonists.
Main Methods:
- Review of existing literature on inverse agonism and GPCR signaling.
- Application of mathematical modeling to simulate inverse agonist effects.
- Computational techniques to analyze dynamic physiological responses.
Main Results:
- Numerical simulations demonstrate diverse dynamic features of inverse agonism.
- Observed effects include inhibition of agonist-induced responses and undershoots.
- Both surmountable and insurmountable inverse agonism were characterized.
Conclusions:
- Mathematical and computational approaches are vital for understanding inverse agonism in GPCR systems.
- These methods support experimental observations and enable quantitative characterization of ligand-receptor interactions.
- Predictive modeling aids in the rational design of drugs targeting GPCRs.
More Related Videos
13:34A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
09:03Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay
Published on: March 10, 2020
Related Concept Videos
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with one...
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model
Pharmacodynamic Models: Overview
Agonism and Antagonism: Quantification
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
Pharmacodynamic Models: Additive and Proportional Drug Effect Model